Loading...

PE anti-mouse Ly-6G Antibody

Pricing & Availability
Clone
1A8 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus G
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
1A8_PE_090808.jpg
C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
  • 1A8_PE_090808.jpg
    C57BL/6 bone marrow cells stained with 1A8 PE (gated on myeloid cells)
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
127607 50 µg 134 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
127608 200 µg 283 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Lymphocyte antigen 6 complex, locus G (Ly-6G), a 21-25 kD GPI-anchored protein, is expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Ly-6G transfected EL-4J cell line.
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

While 1A8 recognizes only Ly-6G, clone RB6-8C5 recognizes both Ly-6G and Ly-6C. Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C15. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A815. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.416.

Additional reported applications (for the relevant formats) include: immunohistochemistry9 of frozen sections10 and paraffin-embedded sections11, depletion4, 12-14, and spatial biology (IBEX)20,21. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for in vivo studies or highly sensitive assays (Cat. No. 127632, 127649, 127650, 127661 and 127662).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (FC)
  2. Daley JM, et al. 2008. J. Leukocyte Biol. 83:1. (FC)
  3. Dietlin TA, et al. 2007. J. Leukocyte Biol. 81:1205. (FC)
  4. Daley J, et al. 2007. J. Leukocyte Biol. doi:10.1189. (Deplete) PubMed
  5. Tadagavadi RK, et al. 2010. J. Immunol. 185:4904. PubMed
  6. Sumagin R, et al. 2010. J. Immunol. 185:7057. PubMed
  7. Guiducci C, et al. 2010. J. Exp Med. 207:2931. PubMed
  8. Fujita M, et al. 2011. Cancer Res. 71:2664. PubMed
  9. Van Leeuwen, et al. 2008. Arterioscler. Thromb. Vasc. Biol. 28:84. (IHC)
  10. Kowanetz M, et al. 2010. P. Natl. Acad. Sci. USA 107:21248. [supplementary data] (IHC)
  11. Esbona K, et al. 2016. Breast Cancer Res. 18:35. (IHC)
  12. Wojtasiak M, et al. 2010. J. Gen. Virol. 91:2158. (FC, Deplete)
  13. Jaeger BN, et al. 2012. J. Exp. Med. 209:565. (Deplete)
  14. Wozniak KL, et al. 2012. BMC Immunol. 13:65 (FC, Deplete)
  15. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  16. Ng LG, et al. 2011. J Invest. Dermatol. 131:2058. PubMed
  17. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  18. McCartney-Francis, N, et al. 2014. J Leukoc. Biol. 96:917. PubMed
  19. Her Z, et al. 2014. EMBO Mol. Med. 7:24. PubMed
  20. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  21. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Combes F, et al. 2018. Neoplasia. 20:848. PubMed
  2. de la Rosa X, et al. 2018. Am J Pathol. 188:950. PubMed
  3. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  4. Sierro F, et al. 2017. Immunity. 47:374. PubMed
  5. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  6. Christian DA, et al. 2022. Sci Immunol. 7:eabq7432. PubMed
  7. Pagni RL, et al. 2022. Front Immunol. 13:1005937. PubMed
  8. Matter AL, et al. 2022. J Immunol. 209:1880. PubMed
  9. Mizutani T, et al. 2023. iScience. 26:106081. PubMed
  10. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  11. Zhu S, et al. 2023. J Nanobiotechnology. 21:81. PubMed
  12. Chung JY, et al. 2023. Nat Commun. 14:1794. PubMed
  13. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  14. Cozzolino M, et al. 2023. Int J Mol Sci. 24:. PubMed
  15. Kase N, et al. 2023. Front Cell Dev Biol. 11:1022081. PubMed
  16. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  17. Roy S, et al. 2023. J Clin Invest. 133:. PubMed
  18. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  19. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  20. Zhao D, et al. 2021. Innate Immun. 27:533. PubMed
  21. Zhou R, et al. 2022. EBioMedicine. 75:103762. PubMed
  22. Volmari A, et al. 2021. Hepatol Commun. 5:2104. PubMed
  23. Da Mesquita S, et al. 2021. Nature. 593:255. PubMed
  24. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  25. MacLean AJ, et al. 2022. Immunity. 55:718. PubMed
  26. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  27. Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed
  28. Xu J, et al. 2022. Invest Ophthalmol Vis Sci. 63:15. PubMed
  29. Wu X, et al. 2022. J Clin Med. 11: . PubMed
  30. Gong F, et al. 2023. Adv Healthc Mater. 12:e2201771. PubMed
  31. Hopke A, et al. 2022. iScience. 25:105226. PubMed
  32. Nagre N, et al. 2022. Respir Res. 23:326. PubMed
  33. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  34. Wang Y, et al. 2023. FASEB J. 37:e22776. PubMed
  35. Pinto NA, et al. 2023. Cell Death Differ. :. PubMed
  36. Meng S, et al. 2023. Stem Cell Investig. 10:2. PubMed
  37. He Y, et al. 2023. Nat Commun. 14:691. PubMed
  38. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  39. De Giovanni M, et al. 2022. Cell. 185:815. PubMed
  40. Ma Y, et al. 2022. Am J Physiol Heart Circ Physiol. 322:H622. PubMed
  41. Kraynak CA, et al. 2022. Int J Pharm. 618:121634. PubMed
  42. Lee T, et al. 2014. Mol Biol Cell. 25:583. PubMed
  43. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  44. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  45. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  46. Bowling S, et al. 2020. Cell. 181(6):1410-1422.e27. PubMed
  47. Jung J, et al. 2019. Cell Host Microbe. 25:513. PubMed
  48. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  49. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  50. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  51. Gawish R, et al. 2022. Elife. 11:. PubMed
  52. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  53. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  54. Ancey PB, et al. 2021. Cancer Res. 81:2345. PubMed
  55. Machata S, et al. 2021. Front Immunol. 11:565869. PubMed
  56. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  57. Cai B, et al. 2016. Proc Natl Acad Sci U S A. 113: 6526 - 6531. PubMed
  58. Kozik J, et al. 2016. Sci Rep. 6:28556. PubMed
  59. Herz J, et al. 2015. J Exp Med. 212: 1153 - 1169. PubMed
  60. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  61. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  62. Kenichi Shimada et al. 2018. Immunity. 49(5):873-885 . PubMed
  63. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  64. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  65. Putnam NE, et al. 2019. PLoS Pathog. 15:e1007744. PubMed
  66. Hanhai Z, et al. 2021. Aging (Albany NY). 13:13108. PubMed
  67. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  68. Ajendra J, et al. 2016. Sci Rep. 6:39648. PubMed
  69. Bottek J, et al. 2020. Mucosal Immunol. 1.029166667. PubMed
  70. Sharma K, et al. 2021. Cell Reports. 36(3):109351. PubMed
  71. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  72. Ishii T,et al. 2017. Sci Rep.. 10.1038/s41598-017-12513-1. PubMed
  73. Xie D, et al. 2017. PLoS One. 10.1371/journal.pone.0181454. PubMed
  74. Muhammad W, et al. 2022. Acta Biomater. 148:258. PubMed
  75. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  76. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  77. Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
  78. Montufar-Solis D, Klein J 2016. PLoS One. 11: 014611. PubMed
  79. Sun P, et al. 2015. J Hepatol. . PubMed
  80. Okada M, et al. 2014. J Biol Chem. 289:32926. PubMed
  81. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  82. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  83. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  84. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  85. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  86. Dolgova EV, et al. 2022. Int J Mol Sci. 23:. PubMed
  87. Papafragkos I, et al. 2022. Front Immunol. 13:889075. PubMed
  88. Harding M, et al. 2014. PLoS Pathog. 10:1004379. PubMed
  89. Morales D, et al. 2015. J Virol. 89:337. PubMed
  90. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  91. Iwata H, et al. 2016. Nat Commun. 7:12849. PubMed
  92. Yeo WS, et al. 2020. J Bacteriol. 202:00:00. PubMed
  93. Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
  94. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  95. Mastandrea I, et al. 2022. STAR Protoc. 3:101106. PubMed
  96. Ma M, et al. 2021. Front Immunol. 12:718779. PubMed
  97. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  98. Lemon J, et al. 2015. Infect Immun . 83: 3204-3212. PubMed
  99. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  100. Schaffert A, et al. 2020. Front Immunol. 10:3024. PubMed
  101. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  102. Shin SH, et al. 2022. Front Cell Neurosci. 16:844480. PubMed
  103. Zhang J, et al. 2022. iScience. 25:104963. PubMed
  104. Metzger D, et al. 2015. J Infect Dis. 212: 445-452. PubMed
  105. Winkler MJ, et al. 2020. Basic Res Cardiol. 115:67. PubMed
  106. Ku MW, et al. 2020. Cell Host Microbe. 29(2):236-249.e6. PubMed
  107. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  108. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  109. Hegde S, et al. 2020. Cancer Cell. 37(3):289-307. PubMed
  110. Al Mamun A, et al. 2019. Neurochem Int. 127:148. PubMed
  111. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  112. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  113. McLaughlin PA et al. 2019. PLoS Pathog. 15(7):e1007847 . PubMed
  114. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  115. Soto-Díaz K, et al. 2021. Front Immunol. 12:734349. PubMed
  116. Qiu Z, et al. 2016. Sci Rep. 6:31936. PubMed
  117. Kojo K, et al. 2016. Sci Rep. 6:29650. PubMed
  118. Hulsmans M et al. 2017. Cell. 169(3):510-522 . PubMed
  119. Si Y, et al. 2018. J Control Release. 282:120. PubMed
  120. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  121. El-Zaatari M, et al. 2014. J Immunol. 193:807. PubMed
  122. Markman JL, et al. 2020. Nat Commun. 11:1613. PubMed
  123. Wheeler MA, et al. 2019. Cell. 176:581. PubMed
  124. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  125. Zhou Z, et al. 2022. Life (Basel). 12:. PubMed
  126. Baik JE, et al. 2022. Clin Transl Med. 12:e758. PubMed
  127. Yong L, et al. 2022. Nat Commun. 13:4255. PubMed
  128. Catani J, et al. 2016. Transl Oncol. 9:565-574. PubMed
  129. Zhou G, et al. 2019. FASEB J. 33:11396. PubMed
  130. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  131. Su M, et al. 2022. Nat Cardiovasc Res. 1:732. PubMed
  132. Coquery C, et al. 2014. PLoS One. 9:102284. PubMed
  133. Umeshappa CS, et al. 2021. Cell Reports. 34(13):108919. PubMed
  134. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  135. Kim Y, et al. 2012. J Immunol. 188:4226. PubMed
  136. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  137. Rynkiewicz NK, et al. 2020. Sci Signal. 13:. PubMed
  138. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  139. Sanmarco LM, et al. 2021. Nature. 590:473. PubMed
  140. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  141. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  142. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  143. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  144. Unudurthi SD, et al. 2020. Life Sci. 117440:247. PubMed
  145. Finsterbusch M, et al. 2014. J Exp Med. 211:1307. PubMed
  146. Vergadi E, et al. 2014. J Immunol. 192:394. PubMed
  147. Kimura H, et al. 2019. Sci Rep. 9:5887. PubMed
  148. Hsu BE et al. 2019. Cell Rep. 27(13):3902-3915 . PubMed
  149. Su W et al. 2019. Cancer Cell. 36(2):139-155 . PubMed
  150. Bronisz–Budzynska I, et al. 2019. Skelet Muscle. 9:22. PubMed
  151. Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed
  152. Takizawa S, et al. 2022. Mol Med. 28:91. PubMed
  153. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  154. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  155. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  156. Kim M, et al. 2018. Immunity. 49:151. PubMed
  157. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  158. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  159. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  160. Murray MP, et al. 2022. Cell Rep. 38:110209. PubMed
  161. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  162. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  163. Penke LR, et al. 2020. Life Sci Alliance. 3:. PubMed
  164. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  165. Swanson P, et al. 2016. PLoS Pathog. 12:e1006022. PubMed
  166. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  167. Laban H, et al. 2018. J Cell Biol. 217:1503. PubMed
  168. Chiang N, et al. 2019. J Clin Invest. 129:5294. PubMed
  169. Eislmayr K, et al. 2022. Sci Adv. 8:eabj7293. PubMed
  170. Unsinger J, et al. 2021. J Leukoc Biol. 109:697. PubMed
  171. Liu Y, et al. 2015. BioMed Res Int. 2015 563425. PubMed
  172. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  173. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  174. Buerfent BC, et al. 2019. GMS Infect Dis. 7:Doc04. PubMed
  175. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  176. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  177. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  178. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  179. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  180. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  181. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  182. Zheng Y, et al. 2022. J Immunol. 208:501. PubMed
  183. Issah Y, et al. 2021. Elife. 10:. PubMed
  184. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  185. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  186. Huang W, et al. 2016. Cell Death Differ. 10.1038/cdd.2016.115. PubMed
  187. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  188. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  189. Weckbach LT, et al. 2019. J Exp Med. 216:350. PubMed
  190. Subramaniam N, et al. 2021. Blood Adv. 5:1259. PubMed
  191. Li Y, et al. 2022. Theranostics. 12:5364. PubMed
  192. Zhai T, et al. 2020. Clin Exp Pharmacol Physiol. 47:677. PubMed
  193. Kimura T, et al. 2014. Int Immunol. 26:697. PubMed
  194. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  195. Hu R, et al. 2015. J Immunol. 195: 4802 - 4809. PubMed
  196. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  197. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  198. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  199. Li Y, et al. 2020. Theranostics. 10:11376. PubMed
  200. Nguyen HX et al. 2017. J Neurosci. 37(38):9269-9287 . PubMed
  201. Moraes JA, et al. 2018. J Innate Immun. 11:330. PubMed
  202. Zhao Z, et al. 2019. J Immunol Res. 2019:9561350. PubMed
  203. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  204. Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
  205. Ishihara J, et al. 2018. Nat Commun. 9:2163. PubMed
  206. Bozoglu T, et al. 2022. Adv Sci (Weinh). 9:e2103867. PubMed
  207. Chen YL, et al. 2022. Front Neurosci. 16:876582. PubMed
  208. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  209. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  210. Guo H, et al. 2016. J Immunol. 196: 2300 - 2308. PubMed
  211. Wang C, et al. 2020. Mucosal Immunol. 13:22. PubMed
  212. Weng JH, et al. 2021. Nat Metab. 3:513. PubMed
  213. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  214. Zha ZX, et al. 2022. Acta Pharmacol Sin. :. PubMed
  215. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  216. Hou Y, et al. 2013. J Nutr Biochem. 24:1555. PubMed
  217. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  218. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  219. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  220. Wang X, et al. 2021. Immunity. 54(6):1123-1136.e8. PubMed
  221. Schuran FA, et al. 2020. Cell Mol Gastroenterol Hepatol. . PubMed
  222. Wheeler MA, et al. 2020. Nature. 578:593. PubMed
  223. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  224. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  225. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  226. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  227. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
  228. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  229. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  230. Rodgers M, et al. 2014. J Exp Med. 211:1333. PubMed
  231. Hellmann J, et al. 2013. J Immunol. 191:1383. PubMed
RRID
AB_1186104 (BioLegend Cat. No. 127607)
AB_1186099 (BioLegend Cat. No. 127608)

Antigen Details

Structure
A 21-35 kD GPI-anchorded membrane protein
Distribution

Expressed on the majority of myeloid cells in bone marrow and peripheral granulocytes. The monoclonal antibody RB6-8C5 recognizes both Ly-6G and Ly-6C.

Cell Type
Granulocytes, Macrophages, Monocytes
Biology Area
Immunology, Innate Immunity
Antigen References

Fleming TJ, et al. 1993. J. Immunol. 151:2399.

Gene ID
546644 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
Ly-6G
Specificity Alt (DOES NOT SHOW ON TDS):
Ly-6G
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about Ly-6G on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All Ly-6G Reagents Request Custom Conjugation
Description Clone Applications
Alexa Fluor® 594 anti-mouse Ly-6G 1A8 IHC-F,SB
Purified anti-mouse Ly-6G 1A8 FC,IHC-F,IHC-P,SB
Biotin anti-mouse Ly-6G 1A8 FC,IHC
FITC anti-mouse Ly-6G 1A8 FC
PE anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 647 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Pacific Blue™ anti-mouse Ly-6G 1A8 FC
APC anti-mouse Ly-6G 1A8 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G 1A8 FC
PE/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 700 anti-mouse Ly-6G 1A8 FC,IHC
APC/Cyanine7 anti-mouse Ly-6G 1A8 FC
Alexa Fluor® 488 anti-mouse Ly-6G 1A8 FC,IHC-F,SB
Brilliant Violet 421™ anti-mouse Ly-6G 1A8 FC,IHC-F
Brilliant Violet 570™ anti-mouse Ly-6G 1A8 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G 1A8 FC,Depletion,IHC
Brilliant Violet 510™ anti-mouse Ly-6G 1A8 FC
Purified anti-mouse Ly-6G (Maxpar® Ready) 1A8 FC,CyTOF®,WB
Brilliant Violet 650™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 711™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 605™ anti-mouse Ly-6G 1A8 FC
Brilliant Violet 785™ anti-mouse Ly-6G 1A8 FC
PE/Dazzle™ 594 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 750 anti-mouse Ly-6G 1A8 FC
PerCP anti-mouse Ly-6G 1A8 FC
TotalSeq™-A0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-C0015 anti-mouse Ly-6G 1A8 PG
TotalSeq™-B0015 anti-mouse Ly-6G 1A8 PG
Spark Blue™ 550 anti-mouse Ly-6G 1A8 FC
Spark NIR™ 685 anti-mouse Ly-6G 1A8 FC
Spark YG™ 593 anti-mouse Ly-6G 1A8 FC
APC/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
PE/Cyanine5 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 810 anti-mouse Ly-6G Antibody 1A8 FC
Spark UV™ 387 anti-mouse Ly-6G 1A8 FC
PE/Fire™ 640 anti-mouse Ly-6G 1A8 FC
Spark YG™ 570 anti-mouse Ly-6G 1A8 IHC-F,FC
Go To Top Version: 3    Revision Date: 01.06.2017

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account